Biocare Medical, LLC
4040 Pike Lane
18 articles with Biocare Medical, LLC
Biocare Medical Launches 3 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research: BAP1, BCA-225 [Cu-18] and SMAD4 [EP618Y]
Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of three novel IVD IHC antibody markers at the forefront of clinical diagnostic and research applications.
Biocare Medical and Bethyl Laboratories Announce the Launch of TIGIT IVD Rabbit Monoclonal Antibody for Immunohistochemical Applications
Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic use in the qualitative identification of the TIGIT protein by immunohistochemistry in formalin-fixed paraffin-embedded human tissues.
Biocare Medical , a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics. Bethyl Laboratories has 45 years of experience in
Biocare Medical MACH4 Universal Polymer Utilized by CDC for Immunohistochemical Detection of SARS-CoV-2 in COVID-19 Caused Respiratory Infections
Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents, instrumentation and detection systems has been mentioned in a recent early release study by the Centers for Disease Control: Pathology and Pathogensis of SARS-CoV-2 Associated with Fatal Corona Virus Disease. The ongoing pandemic
Biocare Medical (“Biocare”), a leading developer of world class immunohistochemistry (“IHC”) and molecular reagents and instrumentation, is pleased to announce that Luis de Luzuriaga has joined the company as Chief Executive Officer.
Biocare Medical Launches 7 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research Applications with a Focus on Immuno-Oncology
SAN FRANCISCO , Feb. 20, 2020 /PRNewswire/ -- Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage canc
Biocare Medical, a leading developer of world-class immunohistochemistry and molecular reagents and instrumentation, announced the appointment of Nicolas Barthelemy as Executive Chairman. Mr. Barthelemy brings over 25 years of executive leadership experience in the life sciences and diagnostic tools industry.
Biocare Medical Announces Launch of a New p16 INK4a IVD Monoclonal Antibody for Use in Immunohistochemistry
Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) instrumentation and reagents, announces the release of a new mouse monoclonal antibody, p16 INK4a, for in vitro diagnostic (IVD) use in the qualitative identification of the p16 INK4a protein by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues.
Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) instrumentation and reagents, announces the release of the VALENT IVD (in vitro diagnostic) automated staining platform.
Excellere Partners Announces Investment In BioCare Medical, A Leading Provider Of Immunohistochemistry Instrumentation And Reagents
Morphotek Inc. Announces An Agreement With BioCare Medical To Develop And Commercialize A Diagnostic Kit For Detection Of Mesothelin In Malignant Tissues
Applied Spectral Imaging (ASI) And BioCare Medical Partner To Deliver Comprehensive Solutions For Immunohistochemistry
Morphotek Inc. Announces an Agreement with BioCare Medical to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues
BioCare To Present At Medtech Insight And Windhover Information Inc.'s ''In3 Medical Device Summit'' Conference, June 21-23, 2006 In San Francisco, CA
BioCare And Epitomics, Inc. Announce A Strategic Alliance For The Use Of Rabbit Monoclonal Antibody Technology With Double Stain Technology In IHC Diagnostic Applications